Both in Pharmaceuticals
Prelude Therapeutics Incorporated vs Emergent Biosolutions
Over the past year PRLD returned +168.8% and EBS returned −27.8%; their daily moves had a correlation of -0.03.
PRLD +168.8% EBS −27.8%Growth of $1, one year, split-adjusted
| Metric | PRLD | EBS |
|---|---|---|
| Price | $3.87 | $6.37 |
| Market cap | $308.8M | $326.4M |
| Today | −1.02% | −3.56% |
| 1 month | −29.5% | +2.3% |
| 6 months | +12.2% | −24.0% |
| Year to date | +33.4% | −48.5% |
| 1 year | +168.8% | −27.8% |
| Revenue growth (YoY) | — | +66.3% |
| Gross margin | 100.0% | 58.6% |
| Net margin | −244.1% | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | 13.8× | 0.4× |
| Net cash | $151.8M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 83.9% | 90.0% |
| Short % of float | 21.3% | 19.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).